Divergent Roles for Macrophage C-type Lectin Receptors, Dectin-1 and Mannose Receptors, in the Intestinal Inflammatory Response
- PMID: 32234475
- DOI: 10.1016/j.celrep.2020.03.018
Divergent Roles for Macrophage C-type Lectin Receptors, Dectin-1 and Mannose Receptors, in the Intestinal Inflammatory Response
Abstract
Colonic macrophages are considered to be major effectors of inflammatory bowel diseases (IBDs) and the control of gut inflammation through C-type lectin receptors is an emerging concept. We show that during colitis, the loss of dectin-1 on myeloid cells prevents intestinal inflammation, while the lack of mannose receptor (MR) exacerbates it. A marked increase in dectin-1 expression in dextran sulfate sodium (DSS)-exposed MR-deficient mice supports the critical contribution of dectin-1 to colitis outcome. Dectin-1 is crucial for Ly6ChighCCR2high monocyte population enrichment in the blood and their recruitment to inflamed colon as precursors of inflammatory macrophages. Dectin-1 also promotes inflammasome-dependent interleukin-1β (IL-1β) secretion through leukotriene B4 production. Interestingly, colonic inflammation is associated with a concomitant overexpression of dectin-1/CCL2/LTA4H and downregulation of MR on macrophages from IBD patients. Thus, MR and dectin-1 on macrophages are important mucosal inflammatory regulators that contribute to the intestinal inflammation.
Trial registration: ClinicalTrials.gov NCT01990716.
Keywords: C-type lectin receptor; Dectin-1; IBD; colitis; inflammatory bowel disease; innate immune response; macrophage; mannose receptor; mucosal immmunity.
Copyright © 2020 The Author(s). Published by Elsevier Inc. All rights reserved.
Conflict of interest statement
Declaration of Interests The authors declare no competing interests.
Similar articles
-
The C-type lectin receptors dectin-1, MR, and SIGNR3 contribute both positively and negatively to the macrophage response to Leishmania infantum.Immunity. 2013 May 23;38(5):1038-49. doi: 10.1016/j.immuni.2013.04.010. Epub 2013 May 16. Immunity. 2013. PMID: 23684988
-
Dectin-2-induced CCL2 production in tissue-resident macrophages ignites cardiac arteritis.J Clin Invest. 2019 Jun 6;129(9):3610-3624. doi: 10.1172/JCI123778. J Clin Invest. 2019. PMID: 31169521 Free PMC article.
-
Impaired COMMD10-Mediated Regulation of Ly6Chi Monocyte-Driven Inflammation Disrupts Gut Barrier Function.Front Immunol. 2018 Nov 14;9:2623. doi: 10.3389/fimmu.2018.02623. eCollection 2018. Front Immunol. 2018. PMID: 30487795 Free PMC article.
-
Development, validation and implementation of an in vitro model for the study of metabolic and immune function in normal and inflamed human colonic epithelium.Dan Med J. 2015 Jan;62(1):B4973. Dan Med J. 2015. PMID: 25557335 Review.
-
Dectin-1 as a therapeutic target for inflammatory bowel disease.Adv Pharmacol. 2024;101:237-264. doi: 10.1016/bs.apha.2024.10.002. Epub 2024 Oct 16. Adv Pharmacol. 2024. PMID: 39521602 Free PMC article. Review.
Cited by
-
siRNA against CD40 delivered via a fungal recognition receptor ameliorates murine acute graft-versus-host disease.EJHaem. 2022 May 6;3(3):849-861. doi: 10.1002/jha2.439. eCollection 2022 Aug. EJHaem. 2022. PMID: 36051085 Free PMC article.
-
Nrf2-mediated ferroptosis inhibition: a novel approach for managing inflammatory diseases.Inflammopharmacology. 2024 Oct;32(5):2961-2986. doi: 10.1007/s10787-024-01519-7. Epub 2024 Aug 10. Inflammopharmacology. 2024. PMID: 39126567 Review.
-
Blocking Dectin-1 prevents colorectal tumorigenesis by suppressing prostaglandin E2 production in myeloid-derived suppressor cells and enhancing IL-22 binding protein expression.Nat Commun. 2023 Mar 17;14(1):1493. doi: 10.1038/s41467-023-37229-x. Nat Commun. 2023. PMID: 36932082 Free PMC article.
-
The Phylogeny, Ontogeny, and Organ-specific Differentiation of Macrophages in the Developing Intestine.Newborn (Clarksville). 2022 Oct-Dec;1(4):340-355. doi: 10.5005/jp-journals-11002-0044. Epub 2022 Dec 23. Newborn (Clarksville). 2022. PMID: 36698382 Free PMC article.
-
The Role of C-Type Lectin Receptor Signaling in the Intestinal Microbiota-Inflammation-Cancer Axis.Front Immunol. 2022 May 10;13:894445. doi: 10.3389/fimmu.2022.894445. eCollection 2022. Front Immunol. 2022. PMID: 35619716 Free PMC article. Review.
Publication types
MeSH terms
Substances
Associated data
LinkOut - more resources
Full Text Sources
Medical
Molecular Biology Databases
Miscellaneous